| 1.51 0.15 (11.03%) | 11-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 | 1-year : | 2.14 |
| Resists | First : | 1.64 | Second : | 1.84 |
| Pivot price | 1.55  |
|||
| Supports | First : | 1.34 | Second : | 1.11 |
| MAs | MA(5) : | 1.45 |
MA(20) : | 1.59 |
| MA(100) : | 1.82 |
MA(250) : | 1.82 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 17.5 |
D(3) : | 15.6 |
| RSI | RSI(14): 45.1 |
|||
| 52-week | High : | 3.02 | Low : | 0.95 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ HCAT ] has closed above bottom band by 41.4%. Bollinger Bands are 19.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.55 - 1.56 | 1.56 - 1.57 |
| Low: | 1.35 - 1.36 | 1.36 - 1.37 |
| Close: | 1.49 - 1.51 | 1.51 - 1.52 |
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and patient safety data, sophisticated analytics, and expert consulting. They also facilitate a national data ecosystem, promoting collaborative thought leadership and shared knowledge to generate groundbreaking insights that redefine healthcare delivery. Established in 2008 and based in South Jordan, Utah, the company was formerly known as HQC Holdings, Inc. before officially becoming Health Catalyst, Inc. in March 2017.
Sun, 15 Nov 2026
Form 4 Health Catalyst Inc: Simeon Kohl (Director, CEO) For: 14 September - Investing.com Nigeria
Thu, 12 Nov 2026
Officer Benjamin Landry reports 99,478 shares for sale at Health Catalyst (HCAT). - Stock Titan
Tue, 10 Nov 2026
SoundHound AI, Health Catalyst, and Toast shares are falling, what you need to know - TradingView
Sun, 08 Nov 2026
Health Catalyst, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Fri, 06 Nov 2026
Health Catalyst Inc (HCAT) (Q3 2026) Earnings Call Highlights: Revenue and EBITDA Beat Guidance ... - Yahoo Finance
Fri, 06 Nov 2026
What Health Catalyst (HCAT) Said on Its Q3 Earnings Call - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 76 (M) |
| Shares Float | 60 (M) |
| Held by Insiders | 9.5 (%) |
| Held by Institutions | 70.3 (%) |
| Shares Short | 2,070 (K) |
| Shares Short P.Month | 2,030 (K) |
| EPS | -2.8 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.9 |
| Profit Margin | -74.3 % |
| Operating Margin | -28 % |
| Return on Assets (ttm) | -5.1 % |
| Return on Equity (ttm) | -84.7 % |
| Qtrly Rev. Growth | -26.3 % |
| Gross Profit (p.s.) | 1.79 |
| Sales Per Share | 3.57 |
| EBITDA (p.s.) | -0.01 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 27 (M) |
| Levered Free Cash Flow | 30 (M) |
| PE Ratio | -0.54 |
| PEG Ratio | 0 |
| Price to Book value | 0.79 |
| Price to Sales | 0.42 |
| Price to Cash Flow | 4.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|